An observational study in Cervical Radicular Pain, Spondylosis, Cervical and Cervical Disc Herniation, sponsored by University Hospital of North Norway. Completed at 1 site in Norway. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.
Sponsored by University Hospital of North Norway · Observational
DCR surgery is generally recommended for patients with severe or progressive limb paresis. The incidence of motor weakness reported to be up to 70%, with a varying recovery rate up to 90%, and the prospects of recovery is most likely dependent on paresis severity and duration. Operative treatment could facilitate earlier recovery, but the evidence is weak and based on smaller and heterogeneous DCM/DCR populations. There is also a lack of knowledge concerning timing of surgery, i.e. the influence of paresis duration, surgical delay and preoperative paresis. It is also unclear if there is an association between the underlying DCR pathology (disc herniation, spondylosis or both) and prognosis. The aim of this sub-study is to assess the frequency and severity of limb preoperative paresis in patients operated for DCR, and to improve prognostication of recovery and timing of surgery. To the best of our knowledge, these issues have not been properly investigated previously.
New knowledge in this field is highly sought by clinicians and can Inform patients, and physicians in shared decision making, i.e. helping them to choose more wisely between different treatment strategies. New insight in this field would be also be useful in clinical guideline development, for reducing surgical practice variation, for modifying outcome expectations, improve patient selection (clinical guideline development) and clinical outcomes of DCR surgery.
The most common cause of cervical operation is Degenerative cervical radiculopathy (DCR), i.e. a neural impingement by disc herniation or spondylotic changes. While pain is often the most prevalent indication of surgery, motor weakness is frequently reported and is associated with less favourable outcome.
Preoperative motor weakness is reported up to 70%. Some studies suggest that both the severity and duration of preoperative motor weakness are associated with persistent postoperative weakness, implying that delayed intervention may reduce the likelihood of full neurological recovery.
Moreover, current evidence does not establish whether surgery is preferable to conservative treatment in patients with motor weakness. The optimal timing of surgery and the grades of weakness most likely to benefit also remain unclear. A systematic review was unable to draw firm conclusions because studies varied substantially in strength assessment methods, outcome definitions, and follow-up duration.
Thomé et al. reported that, in lumbar radiculopathy, the association between early surgery and motor recovery was dependent on both baseline muscle grade and symptom duration.12 However, these findings may not be generalisable to cervical radiculopathy given key anatomical and pathological differences.
This study aims to evaluate the association between the preoperative duration and baseline severity (muscle strength grade) of motor weakness and complete strength recovery at 12 months after surgery for DCR. As a secondary, exploratory aim, we will assess whether there is a severity grade and/or duration window in which the probability of complete recovery is highest.
Primary Objective Evaluate the association of (1) patient-reported duration of weakness prior to surgery (timing proxy) and (2) baseline objective motor deficit severity (MRC grade) with patient-reported complete strength recovery (Yes/No) at 12 months following single-level surgery for cervical radiculopathy.
Exploratory objectives
Secondary Objectives
Hypothesis Our null hypothesis is that the prognosis of recovery for DCR patients with paresis is independent of paresis severity, duration and underlying pathology. Our alternative hypothesis is that the recovery rate of paresis after DCR surgery is less for more severe paresis of longer duration and will vary according to underlying pathology.
Study populations The study will include consecutive patients operated for DCR and registered in NORspine form January 2012 through 2022, approximately 12.000 cases. Patients operated for cervical myelopathy will be excluded. Otherwise patients under the age of 16, those operated for fractures, tumours and primary infections, as well as those unable to give informed consent, are not included in the NORspine.
Data sources The project will use prospectively collected data from The Norwegian registry for spine surgery NORspine as the only data source, The NORspine is a comprehensive national clinical registry, with a capture rate of patients operated for DCR of 80% from in 2021 and a response rate at one year follow up (2022) of 80%. Coverage at the institutional level is 95-100%. A wide range of established and possible prognostic factors are recorded in the NORspine prior to surgery. Patient reported outcome measures (PROMs), are recorded at admission for surgery (baseline) and 3 and 12 months (maximum follow up time) after surgery.
Predictors / Exposure Variables
-Timing proxy: patient-reported weakness duration prior to surgery (registry item; English translation) Baseline question: "Do you have reduced strength (weakness) in the affected shoulder, arm, or hand?" (Yes/No).
If Yes: duration (choose one; optional numeric field where available):
Operationalization (prespecified):
Baseline objective motor deficit severity (MRC) Preoperative MRC grade (0-5) recorded by clinician/surgeon for a prespecified key muscle group corresponding to the index level, according to the institution's standard mapping. The cohort is restricted to objective weakness at baseline (MRC \< 5).
Planned MRC coding (depending on data)
Covariates / confounding control Potential confounders/covariates will be evaluated a priori based on clinical knowledge and registry availability by directed acyclic graph (DAG). Adjusted models will be specified before analysis and will not rely on automated or purely significance-driven variable selection.
Statistical Analysis Plan
Primary Confirmatory Analysis (Prediction of 12-month complete recovery)
Secondary Trajectory Analysis (binary longitudinal strength outcome at 3 and 12 months)
Exploratory Threshold Discovery (Tree-based)
Exploratory Discrimination (ROC/AUC)
•ROC/AUC for models using (a) timing alone, (b) MRC alone, and (c) combined predictors, with internal validation if feasible.
Missing Data
142 studies on the registry are indexed under Spondylosis; 42 are open to participants now.
This study's enrollment of 2,000 is above the median of 100 across 36 observational studies indexed under Spondylosis.
Browse Spondylosis studies →University Hospital of North Norway is the lead sponsor of 152 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study will include consecutive patients operated for DCR and registered in NORspine form January 2012 through 2022, approximately 12.000 cases. Patients operated for cervical myelopathy will be excluded. Otherwise patients under the age of 16, those operated for fractures, tumours and primary infections, as well as those unable to give informed consent, are not included in the NORspine.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patient reported improvement of paresis (complete)
Follow-up strength question (3 and 12 months): "If you had reduced strength (weakness) in your shoulder/arm/hand before the operation-has this changed?" Response options: * Has become completely normal * Has improved * Unchanged * Has worsened Primary endpoint derivation (12 months): * Complete recovery = Yes: "Has become completely normal". * Complete recovery = No: all other responses.
Time frame: 12 month
Neck disability index (NDI)
Neck disability index (NDI) is a measure of neck pain related disability, containing 10 items (pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation), all scored on a 6-point ordinal scale (0-5). The 10 items are summarized and recalculated to a percentage score ranging from 0 to 100 (no to maximum disability). Change from baseline to 12 month follow up will be computed. NDI change will be dichotomized to success yes/no as 35% improvement
Time frame: 12 month
EuroQol-5D (EQ5D)
EuroQoL (EQ-5D-3L) is a generic measurement and preference-weighted measure of health-related quality-of- life based on five dimensions: mobility, self-care, usual activity, pain/discomfort and anxiety/discomfort. For each dimension the patient assesses three possible levels (3L) of problems; "none," "mild to moderate," and "severe." The score ranges from 0.59 to 1, where 1 corresponds to perfect health and 0 to death and negative values worse than death. In the second part, called the EQ-VAS, the patient is asked to indicate overall health on a vertical analogue scale, ranging from 0 to 100 ("worst to "best imaginable health").
Time frame: 12 month
Patient and surgeon reported complications
intra and post operativ complications
Time frame: 12 month
NRS head
Numeric Rating Scale for Headache (NRS-HA) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.
Time frame: 12 month
NRS neck
Numeric Rating Scale for neck (NRS-NE) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.
Time frame: 12 month
NRS head
Numeric Rating Scale for arm (NRS-AR) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.
Time frame: 12 month
Improved or complete recovery
Follow-up strength question (3 and 12 months): "If you had reduced strength (weakness) in your shoulder/arm/hand before the operation-has this changed?" Response options: * Has become completely normal * Has improved * Unchanged * Has worsened * Binary outcome improvement (yes/no) at 3 and 12 months: yes (Has become completely normal and Has improved) and no (Unchanged and Has worsened)
Time frame: 12 and 3 month
Plan to share: Undecided — Do to norwegian privacy and research laws
Ran from Jan 2012 to primary completion in Dec 2023, 143 months.
Of 18 observational studies under Spondylosis, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 74. This study's 143 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital of North Norway →